0001183740-20-000216.txt : 20201007 0001183740-20-000216.hdr.sgml : 20201007 20201006173418 ACCESSION NUMBER: 0001183740-20-000216 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201007 DATE AS OF CHANGE: 20201006 EFFECTIVENESS DATE: 20201007 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BRIGHT MINDS BIOSCIENCES INC. CENTRAL INDEX KEY: 0001827401 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-377277 FILM NUMBER: 201227659 BUSINESS ADDRESS: STREET 1: 1500 - 1055 WEST GEORGIA ST. CITY: VANCOUVER STATE: A1 ZIP: V6E 4N7 BUSINESS PHONE: 6474072515 MAIL ADDRESS: STREET 1: 1500 - 1055 WEST GEORGIA ST. CITY: VANCOUVER STATE: A1 ZIP: V6E 4N7 D 1 primary_doc.xml X0708 D LIVE 0001827401 BRIGHT MINDS BIOSCIENCES INC. 1500 - 1055 WEST GEORGIA ST. VANCOUVER A1 BRITISH COLUMBIA, CANADA V6E 4N7 6474072515 BRITISH COLUMBIA, CANADA 1210954 B.C. Ltd. None Corporation true 2019 Ian McDonald 1500 - 1055 West Georgia St. Vancouver A1 BRITISH COLUMBIA, CANADA V6E 4N7 Executive Officer Director Revati Shreeniwas 1500 - 1055 West Georgia St. Vancouver A1 BRITISH COLUMBIA, CANADA V6E 4N7 Executive Officer Chief Medical Officer Biotechnology Decline to Disclose 06b false 2020-09-18 true true true true true Restricted Share Units (RSUs) convertible into shares upon settlement of the RSU. The RSUs will vest over a period of 4 years. false 0 218040 218040 0 Total Offering Amount represents deemed issuance price of 575,000 RSUs at C$0.50 per share. There is no assurance that these securities will vest prior to settlement. Exchange rate of US$1: CDN$1.3186 on September 18, 2020. false 1 0 0 0 false BRIGHT MINDS BIOSCIENCES INC. /s/ Ian McDonald Ian McDonald Director 2020-10-01